Industry Insight
Information, Observation & Analysis
Cardiovascular disease poses a significant risk for women, yet most women remain unaware mainly due to myths and misconceptions.
Recent disease trends among adolescents and young adults have fueled vaccine schedule updates. Many have been outbreak-driven; others reflect vaccine improvements and innovations. All are critical to improve the health.
Vaccine adherence rates for seniors are low, increasing health risks for this older population and beyond.
A growing body of evidence suggests known pharmacologic properties of human albumin may contribute to reducing the risk of a range of cirrhosis complications, including bacterial sepsis, irreversible renal injury and death.
Little is understood about what’s behind increasing ADHD rates in reproductive-age women, thus more research is needed to clarify how medicines to treat the disorder will affect them and their unborn children.
Typically treated with supportive care, this common human infection usually resolves in weeks with some symptoms persisting for months.
To advance scientific discovery and improve patient outcomes, new programs being introduced to increase transparency in data collection and patient engagement are on the rise.
Despite education and intervention efforts, suicide rates are at a global all-time high. As surviving loved ones suffer, public health officials struggle to find solutions to a problem that is both pervasive and complex.
This common virus manifests in a host of systemic illnesses that are mostly curable with human intravenous immune globulin therapy.
A host of programs continue to be implemented in the United States and globally to address antibiotic-resistant illnesses.
Findings from Grifols’ Phase IIb Alzheimer Management by Albumin Replacement (AMBAR) clinical trial found long-term plasmapheresis with albumin replacement reduced disease progression in a prespecified subset of patients with AD of moderate severity.
Until more is discovered about the causes of autoimmune disorders, these chronic but sometimes fatal disorders will continue to increase in numbers of diseases and individuals affected.